-
National HealthCare Corporation (NHC $193.65)
- $193.65 P/E (TTM): 25.15X Cap: $2.96B
- View NHC Profile
- View Questions on NHC
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
uniQure N.V. (QURE $27.05)
- $27.05 Cap: $1.74B
- View QURE Profile
- View Questions on QURE
-
Doximity Inc. Class A (DOCS $18.97)
- $18.97 P/E (TTM): 15.01X Cap: $3.50B
- View DOCS Profile
- View Questions on DOCS
-
ADMA Biologics Inc (ADMA $8.27)
- $8.27 P/E (TTM): 12.5X Cap: $1.91B
- View ADMA Profile
- View Questions on ADMA
-
National HealthCare Corporation (NHC $193.65)
- $193.65 P/E (TTM): 25.15X Cap: $2.96B
- View NHC Profile
- View Questions on NHC
-
Corvus Pharmaceuticals Inc. (CRVS $12.31)
- $12.31 Cap: $1.32B
- View CRVS Profile
- View Questions on CRVS
Q: Hi team,
In attempting to increase the health sector and possibly the international percentage of my portfolio, I am considering the following stocks: ADMA,NHC, QURE,DOCS, CRVS.
Would you recommend any of these or any others for a growth portfolio at this time ?
Gratefully,
Jacques IDS
In attempting to increase the health sector and possibly the international percentage of my portfolio, I am considering the following stocks: ADMA,NHC, QURE,DOCS, CRVS.
Would you recommend any of these or any others for a growth portfolio at this time ?
Gratefully,
Jacques IDS
Insiders
Share Information
SEC Filings
News and Media